http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising. http://www.physorg.com/news180716396.html Medicine & Health Tue, 22 Dec 2009 15:20:03 EST news180716396 Compared to the general population, patients starting dialysis have an increased risk of death that is not attributable to a higher rate of death from cardiovascular causes, as previously thought, according to a study in the October 28 issue of JAMA. http://www.physorg.com/news175885310.html Medicine & Health Tue, 27 Oct 2009 18:30:01 EST news175885310 An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), but is associated with a significant reduction in the risk of one of these events, nonfatal stroke, although the findings may be limited by the lack of a large study population, according to an article in the May 13 issue of JAMA. http://www.physorg.com/news161365561.html Medicine & Health Tue, 12 May 2009 16:46:23 EST news161365561 New research out of Wake Forest University School of Medicine shows that use of the most commonly prescribed once-a-day treatment for chronic obstructive pulmonary disease (COPD) for longer than one month increases the risk of cardiovascular death, heart attack or stroke by more than 50 percent. http://www.physorg.com/news141404274.html Medicine & Health Tue, 23 Sep 2008 15:57:54 EST news141404274 An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment. http://www.physorg.com/news139410726.html Medicine & Health Sun, 31 Aug 2008 14:12:06 EST news139410726